Big Move For Emergent BioSolutions Inc.
Emergent BioSolutions Inc. (EBS:NYSE) rocketted at $2.71, a gain of 78.3%. On Wed, Feb 21, 2024, EBS:NYSE touched a New 2-Week High of $2.71. The stock appeared on our News Catalysts scanner on Tue, Feb 13, 2024 at 08:29 AM in the 'MISCELLANEOUS' category. From Wed, Feb 07, 2024, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Thu, Aug 31, 2023 at $5.42 with a volume of 5M+.
About Emergent BioSolutions Inc. (EBS:NYSE)
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 172.73%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 94.26%
- Emergent BioSolutions Inc. (EBS:NYSE), 78.29%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 78.11%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 68.63%
- Ventyx Biosciences Inc. (VTYX:NASDAQ), 68.56%
- Energy Focus, Inc. (EFOI:NASDAQ), 65.94%
- Origin Agritech Limited (SEED:NASDAQ), 62.93%
- LIZHI INC. (SOGP:NASDAQ), 56.74%
- Quantum FinTech Acquisition Corporation (QFTA:NYSEMKT), 51.33%